Autori: Sierzega M
| Naslov | Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial (Meeting Abstract) |
| Autori | Hua Le Bar-Or Amit Weber Martin Habek Mario Budincevic Hrvoje Thomas Piia Napieralski Julie Ratchford J Qi Qi Sierzega M Drulovic Jelena S |
| Info | EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
